Weight & Measure

Michael Donnelly-Boylen & Zach Niemiec
  • 5.0 (23)
  • Medicine

Weight & Measure with Mike and Zach is an obesity podcast featuring conversations with patients, obesity medicine physicians, metabolic & bariatric surgery experts, researchers, dietitians, and advocates. We explore GLP-1 medications, obesity management medications (OMMs), weight loss medications, bariatric surgery, nutrition, body composition, obesity research, patient advocacy, insurance access, and long-term obesity treatment. Every episode combines lived experience with clinical expertise to support patients and healthcare professionals.

Episodes

  1. Jul 9

    Episode 9: GLP-1 TikTok: Helping or Hurting Patients? | Wegovy, Zepbound, Ozempic & Social Media

    Is GLP-1 TikTok helping or hurting patients? Millions of people living with obesity turn to TikTok every day for information, support, motivation, and community. But as obesity management medications like Wegovy®, Zepbound®, Ozempic®, and Mounjaro® become increasingly common, social media has also become one of the most influential sources of obesity treatment information. So who is shaping the conversation? In this episode of Weight & Measure, hosts Mike Donnelly-Boylen and Zach Niemiec are joined by Dr. Danna Kashlan of Johns Hopkins Medicine and Dr. Lindsey Ogle for an important discussion inspired by Dr. Kashlan's research presented at the 2026 American Diabetes Association Scientific Sessions. Her research, "Who Shapes the GLP-1 Narrative on TikTok?", examined highly engaged GLP-1 content and found that patients, not healthcare professionals, are driving much of the conversation online. Together, we explore the growing influence of social media on obesity care and ask an important question: Is GLP-1 TikTok helping patients, hurting patients, or both? • Why GLP-1 TikTok has become one of the largest online communities for people living with obesity • The benefits of peer support, shared lived experience, and patient advocacy • The risks of misinformation, comparison culture, unrealistic expectations, and viral health advice • How healthcare professionals can better understand the online communities their patients participate in • How patients can identify trustworthy obesity medicine information online • Why lived experience and evidence based medicine should work together, not compete • The future of obesity care in the age of social media Whether you're taking Wegovy®, Zepbound®, Ozempic®, Mounjaro®, another obesity management medication, considering treatment, supporting someone living with obesity, creating health content online, or working in obesity medicine, this episode offers an honest and balanced conversation about one of the fastest growing influences on modern obesity care. Weight & Measure with Mike and Zach is a live panel series bringing together leading obesity medicine physicians, researchers, advocates, and people with lived experience for thoughtful conversations that bridge science, clinical care, and the patient experience. New episodes premiere live on On The Pen before being released on all major podcast platforms. Spotifyhttps://open.spotify.com/show/45vJYXZC0ciTNpfwoc9CVI?si=HicpBPlwQEWD9RhM3t8BjA Apple Podcastshttps://podcasts.apple.com/us/podcast/weight-measure/id1886848263 Amazon Musichttps://music.amazon.com/podcasts/183597e3-d4de-4d93-a7c0-55f0cc6018bd/weight-measure?ref=dm_sh_iwSFqgfpShmLX8vRQR2ZxyJ5y Download the ProCare Health Non-Surgical Weight Loss & Obesity Management Guide to support patients using obesity management medications (OMMs):https://procarenow.com/pages/non-surgical-weight-loss-obesity-management-program

  2. Jun 23

    Episode 8: When Obesity Medicine Gets Personal: Physicians Living with Obesity on GLP-1s, Bariatric Surgery, Med School & Patient Care

    EPISODE DESCRIPTION What happens when the obesity medicine physician is also living with obesity? In this episode of Weight & Measure, hosts Mike Donnelly-Boylen and Zach Niemiec are joined by Dr. Matthea Rentea, Dr. Catherine Toomer, and Dr. Brianna Bingham for an honest conversation about obesity, GLP-1 medications, bariatric surgery, weight stigma, and the realities of treating a disease while also living with it. Together, they discuss their personal obesity journeys, what medical education often gets wrong about obesity, and how lived experience has shaped the way they care for patients. The conversation explores obesity treatment, long-term weight management, bariatric surgery, GLP-1 medications, and the future of obesity medicine. Topics include: • What medical education still gets wrong about obesity• How lived experience changes patient care• GLP-1 medications and obesity treatment• Zepbound, Mounjaro, Wegovy, and Ozempic• Tirzepatide and semaglutide• Bariatric and metabolic surgery• Weight stigma in healthcare• Patient-centered obesity care• Long-term weight management• Obesity advocacy• The future of obesity treatment Dr. Matthea Rentea shares lessons from her personal journey and insights from hundreds of conversations through The Obesity Guide Podcast. Dr. Catherine Toomer discusses maintaining significant weight loss for more than twenty years while helping patients navigate multiple generations of obesity treatment. Dr. Brianna Bingham offers her perspective on bariatric surgery, obesity care, and how personal experience influences clinical practice. Whether you are taking a GLP-1 medication, considering bariatric surgery, living with obesity, supporting a loved one, or working in healthcare, this episode provides a perspective rarely heard in medicine: physicians discussing obesity through both clinical expertise and lived experience. FREE EDUCATIONAL RESOURCE FOR HEALTHCARE PROFESSIONALS If your practice provides non-surgical weight loss, obesity medicine, GLP-1 therapy, or comprehensive obesity care, download ProCare Health's Non-Surgical Weight Loss & Obesity Management Guide: https://procarenow.com/pages/non-surgical-weight-loss-obesity-management-program ABOUT WEIGHT & MEASURE Weight & Measure is hosted by Mike Donnelly-Boylen and Zach Niemiec. The podcast brings together people living with obesity, healthcare professionals, researchers, advocates, and industry leaders to explore obesity care, obesity medicine, bariatric surgery, GLP-1 medications, patient advocacy, weight stigma, and the future of treatment. KEYWORDS obesity, obesity medicine, GLP-1, GLP-1 medications, obesity treatment, obesity care, obesity management medications, OMMs, Zepbound, Mounjaro, Wegovy, Ozempic, tirzepatide, semaglutide, bariatric surgery, metabolic surgery, gastric sleeve, gastric bypass, weight stigma, patient advocacy, obesity advocacy, chronic disease, obesity physician, obesity specialist, lived experience, patient-centered care, Matthea Rentea, Catherine Toomer, Brianna Bingham, The Obesity Guide Podcast, Weight & Measure

  3. Jun 17

    Episode 7: GLP 1 Maintenance: Why Keeping Weight Off Is Harder Than Losing It

    You Lost the Weight. Now What? GLP 1 Maintenance, Mindset, and Long Term Success Many people focus on how to lose weight. Far fewer talk about what happens after. For many individuals using GLP 1 medications, pursuing Bariatric & Metabolic Surgery, or making significant lifestyle changes, reaching a goal weight is not the end of the journey. It is the beginning of a new challenge: maintaining weight loss long term. In this episode of Weight & Measure with Mike and Zach, we explore one of the most important and least discussed topics in obesity care: long term weight maintenance. Joining us are: • Leslie Golden, MD• Robyn Pashby, PhD Together, we discuss why weight recurrence happens, why it is not simply a matter of willpower, and what people can do to build sustainable strategies for long term success. Topics include: • Why keeping weight off is often harder than losing it• The biology behind weight maintenance and weight recurrence• GLP 1 maintenance strategies after active weight loss• Long term use of obesity medications• Hunger, metabolism, and the body's response to weight loss• The psychological challenges of maintaining weight loss• Identity changes after significant weight loss• Fear of weight recurrence and how to navigate it• Perfectionism and all or nothing thinking• Emotional eating, stress, and coping strategies• Building sustainable habits for long term success• Bariatric and metabolic surgery considerations during maintenance• Why body composition may matter more than the scale• The mindset shift from losing weight to living at a lower weight One of the most overlooked realities of obesity treatment is that maintenance is not just a physical challenge. It is also a psychological one. How do you trust yourself after years of weight cycling? How do you respond when the scale moves up? How do you stop living in fear of regaining the weight you worked so hard to lose? Whether your journey includes Wegovy, Zepbound, Mounjaro, GLP 1 medications, Bariatric & Metabolic Surgery, nutrition changes, physical activity, or a combination approach, this episode provides evidence informed insights to help you navigate the next phase of your journey. Weight & Measure with Mike and Zach is a live conversation series bringing together patients, clinicians, researchers, and advocates to discuss obesity medicine, GLP 1 medications, Bariatric & Metabolic Surgery, patient advocacy, and long term health. Keywords: GLP 1 maintenance, weight maintenance, weight loss maintenance, weight recurrence, obesity medicine, obesity care, Ozempic, Wegovy, Zepbound, Mounjaro, Foundayo, semaglutide, tirzepatide, obesity treatment, Bariatric Surgery, Metabolic Surgery, health psychology, emotional eating, weight cycling, body composition, obesity medications, long term weight loss.

  4. Jun 5

    Episode 6: Medicare GLP 1 Coverage: What Older Adults Need to Know About Wegovy, Zepbound & Obesity Care

    Medicare, GLP 1s, and Fear: What Older Adults Need to Know | Angela Fitch, MD, Tracy Zvenyach, PhD, MS, RN, and Deb Cooperman As Medicare coverage for obesity treatment continues to evolve, many older adults are asking the same questions: Can Medicare cover GLP 1 medications like Wegovy or Zepbound? Who qualifies for the Medicare Bridge Program? What should adults over 65 know before starting obesity treatment? In this episode of Weight & Measure with Mike and Zach, we explore the rapidly changing landscape of obesity medicine, Medicare access, and GLP 1 treatment for older adults. Joining us are nationally recognized obesity medicine physician Angela Fitch, MD, obesity policy expert Tracy Zvenyach, PhD, MS, RN, and patient advocate Deb Cooperman to discuss what seniors, caregivers, and healthcare professionals need to know about starting GLP 1 medications later in life. Topics discussed include: • Medicare coverage for GLP 1 medications• The Medicare Bridge Program and who may qualify• Wegovy, Zepbound, Mounjaro, and other obesity medications• Obesity treatment after age 65• Weight loss, muscle loss, and body composition in older adults• Nutrition strategies while taking GLP 1 medications• Side effects and medication expectations• Mobility, strength, and healthy aging• Caregiver and family support during treatment• Access, affordability, and obesity care policy• Bariatric and metabolic surgery considerations• Long-term obesity management and maintenance Whether you are considering Wegovy, Zepbound, Mounjaro, or another obesity treatment, this episode provides evidence-informed insights to help older adults make informed decisions alongside their healthcare team. Resources: • CMS Medicare Bridge Program Information: https://www.cms.gov/glp-1-bridge.pdf Weight & Measure with Mike and Zach is a podcast and live video series bringing together patients, clinicians, researchers, advocates, and policymakers to discuss obesity medicine, GLP 1 medications, Bariatric & Metabolic Surgery, weight management, access to care, and metabolic health. Subscribe for future conversations covering obesity treatment, Medicare policy, weight loss medications, metabolic health, patient advocacy, and evidence-based obesity care. Keywords: Medicare GLP 1 coverage, Medicare Bridge Program, Wegovy Medicare, Zepbound Medicare, Mounjaro Medicare, obesity medicine, obesity treatment for seniors, weight loss after 65, obesity care, metabolic health, obesity advocacy, Angela Fitch, Tracy Zvenyach, Deb Cooperman, Weight & Measure podcast.

  5. May 5

    Episode 5: GLP 1 and Bariatric and Metabolic Surgery Patients How Do You Become an Advocate

    GLP 1 and Bariatric and Metabolic Surgery Patients How Do You Become an Advocate What does it actually take to become a patient advocate in obesity care? In this episode of Weight and Measure, we bring together leading voices across obesity medicine, patient advocacy, and policy to explore how individuals move from lived experience to meaningful impact. As obesity continues to be recognized as a chronic disease, the role of patient advocacy is becoming more critical in shaping access to care, influencing policy decisions, and improving long term health outcomes. From GLP 1 based therapies to Bariatric and Metabolic Surgery, patients are no longer just participants in care. They are becoming active drivers of change. Joining the conversation are: • Robert Kushner, MD• Michele Tedder, RN• James Zervios• Tracy Zvenyach, PhD, MS, RN Together, we break down how advocacy actually happens in the real world. This episode covers:• How patients learn to navigate healthcare systems and advocate for better care• Where clinical intent and lived experience can disconnect• The role of GLP 1 therapies in expanding awareness and access to obesity care• How Bariatric and Metabolic Surgery patients are shaping advocacy efforts• The impact of patient voices on policy, insurance coverage, and treatment access• How organizations like the Obesity Action Coalition support advocacy development• Why community and shared experience are critical to building confident advocates• The importance of events like the Your Weight Matters Convention in empowering patients Whether you are a patient, clinician, or healthcare professional, this episode provides a clear look at how advocacy is evolving and why it matters for the future of obesity care. GLP 1 advocacy, bariatric surgery advocacy, metabolic surgery advocacy, obesity advocacy, patient advocacy, obesity care, GLP 1 medications, Ozempic, Wegovy, Mounjaro, obesity medicine, healthcare policy, insurance coverage, Obesity Action Coalition, Your Weight Matters Convention, chronic disease advocacy, patient voice, metabolic health Links https://www.obesityaction.org/ YWM Regional: https://www.yourweightmatters.com/ YWM National: https://www.ywmconvention.com/?utm_source=zach

  6. Apr 25

    Episode 4: GLP-1 Not Working? Weight Loss Plateau, and What Happens Next

    GLP-1 not working like before? You’re not alone. Many people using GLP-1 medications such as Ozempic, Wegovy, or Mounjaro reach a point where weight loss slows, fatigue increases, and progress feels stalled. This phase is often referred to as a weight loss plateau, but it is frequently misunderstood. In this episode of Weight and Measure, we break down what is actually happening during this stage of the GLP-1 journey and how both patients and clinicians can better navigate it. Zach and Mike are joined by Angela Fitch, MD and Robyn Pashby, PhD to explore the physiological, behavioral, and clinical factors behind stalled progress and what it means for long-term care. This episode covers:• Why GLP-1 medications can feel like they have stopped working• What a weight loss plateau really represents• GLP-1 related fatigue and how to approach it• When to adjust treatment plans and expectations• The shift from weight loss to long term metabolic health• Why body composition matters more than the number on the scale This phase of treatment is where many patients begin to question the process, but it is also where the focus shifts toward sustainability, health outcomes, and long-term success. If you are navigating a plateau, supporting patients on GLP-1 therapy, or working in obesity care, this episode provides practical insight into what comes next. GLP-1 plateau, GLP-1 not working, Ozempic plateau, Wegovy stopped working, Mounjaro weight loss stall, GLP-1 fatigue, weight loss plateau, obesity care, metabolic health, body composition, weight management, obesity medicine

  7. Apr 3

    Episode 3: Weight Bias & Obesity Stigma: How Patient Stories Are Changing Obesity Care

    Episode 3: Weight Bias & Obesity Stigma: How Patient Stories Are Changing Obesity Care Weight bias and obesity stigma continue to affect millions of people living with obesity, influencing healthcare experiences, treatment decisions, mental health, and access to comprehensive obesity care. In this episode of Weight & Measure with Mike and Zach, we explore how patient stories, lived experience, and evidence-based obesity medicine can help reshape the future of obesity care. Originally recorded as one of our live panel discussions, this conversation brings together patients, clinicians, researchers, and advocates to examine how obesity is discussed, understood, and treated—and why reducing weight bias is essential to improving patient outcomes. Joining us for this conversation: • Robyn Pashby, PhD• Leslie M. Golden, MD, MPH, FOMA, Dipl. ABOM• Renee J. Rogers, PhD, FACSM, FTOS• Nina Crowley, PhD, RDN, LD• Ian Patton In this episode, we discuss: • How weight bias and obesity stigma impact patient care and health outcomes• Why patient stories are helping transform obesity care• The importance of respectful, person-first communication in healthcare• Building trust between patients and healthcare professionals• The role of obesity medicine, GLP-1 medications, and metabolic & bariatric surgery within comprehensive obesity care• Why lived experience should help inform research, education, and clinical practice• How advocacy organizations and patient voices are influencing the future of obesity treatment• Practical ways clinicians can create more supportive, evidence-based conversations Whether you're living with obesity, taking a GLP-1 medication, considering or living after metabolic & bariatric surgery, working in obesity medicine, or advocating for more compassionate healthcare, this episode offers practical insights into creating patient-centered, stigma-free obesity care. Weight & Measure with Mike and Zach is an obesity podcast featuring conversations with patients, clinicians, researchers, and advocates about GLP-1 medications, obesity management medications (OMMs), metabolic & bariatric surgery, nutrition, patient advocacy, obesity research, and comprehensive obesity care. Keywords: obesity podcast, weight bias, obesity stigma, weight stigma, obesity care, comprehensive obesity care, obesity medicine, GLP-1, GLP-1 medications, obesity management medications, OMMs, metabolic & bariatric surgery, bariatric surgery, patient advocacy, patient stories, lived experience, patient-centered care, obesity research, healthcare communication, person-first language, healthcare professionals, obesity treatment, chronic disease, obesity education

  8. Mar 29

    Episode 2: How Patient Voices Are Changing Obesity Care

    Episode 2: How Patient Voices Are Changing Obesity Care What happens when people living with obesity help shape healthcare instead of simply navigating it? Recorded live at the Canadian Obesity Summit in Montréal, this episode of Weight & Measure with Mike and Zach explores the growing role of patient advocacy in comprehensive obesity care, obesity medicine, GLP-1 treatment, metabolic & bariatric surgery, healthcare policy, and obesity research. Mike and Zach are joined by leaders from Obesity Canada and respected patient advocates: • Lisa Schaffer• Patty Nece• Ian Patton Together, they discuss: • Why lived experience is essential to improving obesity care• How patient advocates are influencing healthcare policy and obesity research• The future of GLP-1 access and comprehensive obesity care• Reducing weight bias and obesity stigma in healthcare• Shared decision making between patients and healthcare professionals• Building healthcare systems that include patients as partners• Lessons from Obesity Canada's patient-centered approach• Why better obesity outcomes require collaboration among patients, clinicians, researchers, and policymakers Whether you're living with obesity, taking a GLP-1 medication, considering or living after metabolic & bariatric surgery, working in obesity medicine, or advocating for better access to care, this conversation highlights why patient voices are transforming the future of obesity treatment. Weight & Measure with Mike and Zach is an obesity podcast featuring conversations with patients, clinicians, researchers, and advocates about GLP-1 medications, obesity management medications (OMMs), metabolic & bariatric surgery, nutrition, patient advocacy, obesity research, and comprehensive obesity care. Keywords: obesity podcast, obesity care, comprehensive obesity care, obesity medicine, GLP-1, GLP-1 medications, obesity management medications, OMMs, metabolic & bariatric surgery, bariatric surgery, obesity advocacy, patient advocacy, patient engagement, lived experience, obesity research, obesity policy, healthcare policy, Obesity Canada, weight bias, obesity stigma, healthcare innovation, shared decision making, chronic disease, metabolic health, healthcare professionals

  9. Mar 21

    Episode 1: Finding Joy in Movement

    In the first episode of Weight & Measure with Mike and Zach, we bring together patients, providers, and experts for an honest conversation about movement in the context of obesity, GLP-1 medications, and bariatric surgery. Movement is often misunderstood in weight loss and obesity care. For many, it has been shaped by stigma, shame, or the idea that exercise is punishment rather than support. This episode explores how that relationship develops, how it can change, and what movement can look like across a metabolic health journey. We are joined by an incredible panel of experts: • Renee J. Rogers, PhD, FACSM, FTOS• Nina Crowley, PhD, RDN, LD• Jamie Selzler, NASM CPT Together, we discuss: • The lived experience of movement in obesity and weight loss journeys• Why many people develop a negative relationship with exercise• The psychological shift from movement as punishment to movement as care• How GLP-1 medications may change the physiology of movement• What body re composition means and when to focus on it• How to begin movement again after bariatric surgery, GLP-1 treatment, or long periods of inactivity This episode is designed for patients, clinicians, and anyone interested in obesity care, metabolic health, weight management, and sustainable lifestyle change. Weight & Measure with Mike and Zach is a live discussion series that brings together voices across obesity care to create more connected, patient-inclusive conversations. Episodes are recorded live on Dave Knapp’s On the Pen YouTube channel and released as a podcast for re-listening. Keywords: obesity, obesity care, GLP-1, weight loss, bariatric surgery, metabolic health, body recomposition, exercise psychology, movement, weight management, patient perspective, lifestyle change, obesity medicine, fitness after weight loss

  • 9 Episodes

5
out of 5
23 Ratings

About

Weight & Measure with Mike and Zach is an obesity podcast featuring conversations with patients, obesity medicine physicians, metabolic & bariatric surgery experts, researchers, dietitians, and advocates. We explore GLP-1 medications, obesity management medications (OMMs), weight loss medications, bariatric surgery, nutrition, body composition, obesity research, patient advocacy, insurance access, and long-term obesity treatment. Every episode combines lived experience with clinical expertise to support patients and healthcare professionals.

Information

  • Creator
    Michael Donnelly-Boylen & Zach Niemiec
  • Years Active
    2026
  • Episodes
    9
  • Rating
    Clean
  • Copyright
    © Michael Donnelly-Boylen & Zach Niemiec
  • Show Website
    Weight & Measure

You Might Also Like